Can I Get Sleep Apnea Secondary to PTSD? The Medical Evidence, Nexus Strategy, and Why This Claim Gets Denied

Sleep apnea secondary to PTSD is one of the highest-value secondary claims a veteran can file. If granted at the most common 50% rating, it adds approximately $1,149 per month to your compensation.

The legal pathway is well established. Multiple Board of Veterans' Appeals decisions in 2025 have granted service connection for obstructive sleep apnea as secondary to PTSD. The Court of Appeals for Veterans Claims reinforced the framework in Adams v. Collins (July 2025). And the medical evidence connecting PTSD to sleep apnea is overwhelming.

Yet these claims still get denied — often because of avoidable mistakes in how the claim is filed, what evidence is submitted, and when the nexus letter reaches the file.

This guide covers everything you need to know to build the strongest possible claim.

The PTSD-Sleep Apnea Medical Connection

The relationship between PTSD and obstructive sleep apnea is not speculative. It is supported by multiple independent lines of medical research, the VA's own clinical guidelines, and a growing body of case law.

The numbers are stark:

A meta-analysis published in Sleep Medicine found that approximately 75% of participants with PTSD had mild OSA and nearly half had moderate OSA. Zhang et al. (2017) conducted a meta-analysis finding an odds ratio of 2.70 for OSA in PTSD populations — meaning veterans with PTSD are nearly three times more likely to develop sleep apnea than those without it.

Colvonen et al. (2015) documented the bidirectional relationship between PTSD and OSA. Mysliwiec et al. demonstrated that PTSD is independently associated with OSA even after controlling for BMI — meaning the connection exists regardless of whether the veteran is overweight.

A 2024 study in Sleep Health found that 21% of veterans have OSA compared to 9% of non-veterans, and 69.2% of Iraq and Afghanistan veterans were at high risk for OSA.

Four Mechanisms Linking PTSD to Sleep Apnea

BVA decision A25019620 (March 2025) cited a private medical opinion identifying four distinct mechanisms. Understanding these is critical because a strong nexus letter should address multiple pathways:

1. Medication-Induced Weight Gain: PTSD medications — particularly quetiapine (Seroquel), olanzapine, mirtazapine, and risperidone — carry substantial risk of metabolic weight gain. The VA/DoD 2023 Clinical Practice Guidelines for PTSD explicitly acknowledge this risk. Weight gain increases upper airway fat deposition, which causes airway collapsibility during sleep.
2. Dopamine/Food Reward Pathway: PTSD disrupts neurological satiety signals through the dopamine reward system, leading to compensatory overeating and weight gain independent of medication effects.
3. Sleep Disturbance-Induced Weight Gain: Chronic sleep disruption from PTSD (nightmares, hypervigilance, insomnia) independently contributes to metabolic dysfunction and weight gain through hormonal disruption (elevated cortisol, disrupted leptin/ghrelin signaling).
4. Direct Neurobiological Pathway: PTSD causes autonomic nervous system dysregulation and upper airway muscle dysfunction independent of any weight changes. Gray et al. (2017) documented this weight-independent pathway.

The Obesity Intermediate Step — The Legal Pathway That Wins

This is the most important legal concept in PTSD-to-sleep-apnea claims, and the one most veterans and even some VSOs get wrong.

Under 38 CFR § 3.310, you can establish secondary service connection when a service-connected disability caused or aggravated a new condition. The VA has long recognized that obesity can serve as an "intermediate step" in this causal chain — even though obesity itself is not a ratable disability.

Here is how the three-part test works:

1. Step 1: Your service-connected PTSD (or its treatment) caused weight gain / obesity
2. Step 2: That obesity is a substantial contributing factor to your sleep apnea
3. Step 3: Your sleep apnea would not have occurred (or would not be as severe) but for the obesity

This framework was established in Walsh v. Wilkie (2020) and refined in Garner v. Tran, 33 Vet. App. 241 (2021), which enumerated six non-exhaustive factors that support finding obesity as an intermediate step. Critically, Garner factor #3 explicitly lists PTSD medication side effects (specifically weight gain from medication prescribed for a service-connected disability) as a recognized trigger.

Adams v. Collins (CAVC, July 2025)

In Adams v. Collins, No. 23-5064 (July 8, 2025), the Court of Appeals for Veterans Claims rejected the VA's categorical prohibition on treating obesity as a disability for purposes of secondary service connection. The court held that the VA General Counsel opinion (G.C. Prec. 1-2017) imposing that prohibition was an "impermissible interpretation of the statute."

This decision is important for veterans who were previously denied on the basis that "obesity is not a disease or injury." If you received that denial, Adams may constitute new and relevant legal authority for a Supplemental Claim.

Direct Causation vs. Aggravation Theory

Veterans should understand that there are two distinct legal theories for secondary service connection, and you can — and should — pursue both simultaneously.

Theory 1: Direct Causation

Your PTSD (through medication, weight gain, or neurobiological changes) caused your sleep apnea. This is the stronger theory when the veteran did not have sleep apnea before PTSD onset or treatment.

Theory 2: Aggravation

Your PTSD worsened pre-existing sleep apnea beyond its natural progression. This theory applies when the veteran had some degree of sleep apnea before PTSD, but PTSD made it measurably worse. The VA must rate the degree of aggravation — the increase in severity attributable to the service-connected condition.

Why pursue both?

Denial of one theory does not defeat the other. If the C&P examiner finds that PTSD did not cause the sleep apnea, you can still prevail on the aggravation theory (or vice versa). By raising both theories in your initial claim, you create redundant legal hooks that reduce your overall denial risk.

BVA decision A25020949 (March 2025) granted on the obesity intermediate step pathway. But the medical literature also supports the direct PTSD-to-OSA neurobiological pathway independently of weight (Gray et al. 2017, Mysliwiec et al.). A well-built claim raises both.

The Weight Gain Pathway: PTSD Medications and Behavioral Changes

The weight gain pathway is the most frequently granted basis for sleep apnea secondary to PTSD. Understanding the medical specifics strengthens both your nexus letter and your claim submission.

PTSD Medications That Cause Weight Gain

The VA/DoD 2023 Clinical Practice Guidelines for PTSD explicitly acknowledge that several commonly prescribed medications carry "substantial risk of negative metabolic effects on weight." The most significant are:

• Quetiapine (Seroquel): One of the most commonly prescribed off-label medications for PTSD-related sleep disturbance and nightmares. Known for significant metabolic effects.
• Olanzapine: Atypical antipsychotic with well-documented weight gain as a side effect.
• Mirtazapine (Remeron): Antidepressant frequently prescribed for PTSD with appetite stimulation and weight gain.
• Risperidone: Antipsychotic used adjunctively for PTSD symptoms.

Quantifying the Weight-OSA Relationship

The medical literature provides specific, citable statistics that strengthen any nexus letter:

• A 10% increase in body weight is associated with a 32% increase in the Apnea-Hypopnea Index (AHI)
• A one standard deviation increase in BMI is associated with a 4-fold increase in OSA prevalence
• Men who gain 22 or more pounds are 5 times more likely to develop moderate-to-severe OSA (AASM study)

These numbers transform a generic "weight gain causes sleep apnea" argument into a specific, evidence-backed causal chain that is much harder for a C&P examiner to dismiss.

Your Weight Gain Timeline Is Built-in Evidence

Your VA medical records contain a chronological BMI and weight timeline. Mapping your weight data against your PTSD medication start dates and your OSA diagnosis date creates a fact-specific causal narrative. For example:

• Pre-PTSD treatment weight: 180 lbs (BMI 26)
• Quetiapine started: January 2020
• Weight at next annual physical: 215 lbs (BMI 31)
• Sleep study / OSA diagnosis: March 2022

This kind of timeline is substantially more persuasive than a generic statement that "PTSD medication can cause weight gain."

Nexus Letter Requirements — What Your Letter Must Say

The nexus letter is the single most important piece of evidence in a sleep apnea secondary claim. Based on our review of successful BVA decisions, here is what separates a winning nexus letter from one that gets your claim denied.

Required Elements

1. Explicit "at least as likely as not" language: The provider must state that it is at least as likely as not (50% or greater probability) that your sleep apnea was caused by or aggravated by your service-connected PTSD.
2. Multiple mechanism analysis: Address all four pathways (medication, dopamine/reward, sleep disturbance, direct neurobiological). Do not rely on a single mechanism.
3. Specific medication names and start dates: Generic statements about "PTSD medications" are weak. Name the specific drugs, when they were started, and cite the VA/DoD 2023 CPG on metabolic effects.
4. Individualized BMI timeline: Include the veteran's specific pre-treatment weight, post-treatment weight, and the chronological progression.
5. Three-part intermediate step analysis: Explicitly walk through each step: (a) PTSD/PTSD meds caused obesity, (b) obesity is a substantial factor in OSA, (c) OSA would not have occurred but for the obesity.
6. Garner v. Tran citation: Specifically invoke factor #3: "side effects of medication (e.g., weight gain), where the medication is prescribed for a service-connected disability" — Garner v. Tran, 33 Vet. App. 241, 248 (2021).
7. Quantitative weight-OSA data: Cite the medical statistics (10% weight = 32% AHI increase; one SD BMI = 4x OSA prevalence).

Bonus: CPAP-PTSD Interference Opinion

If you have poor CPAP compliance (and most PTSD veterans do — only 41% of veterans with PTSD achieve CPAP adherence compared to 70% without PTSD), ask your provider to include an opinion that your PTSD prevents habitual CPAP use. This documentation protects your 50% rating under both current and proposed regulations.

DC 6847 Rating Criteria — Current Sleep Apnea Ratings

Sleep apnea is rated under Diagnostic Code 6847 (Sleep Apnea Syndromes). The current criteria, which remain in full effect as of March 2026, are:

The most common rating for veterans with diagnosed sleep apnea is 50%, because most veterans who receive an OSA diagnosis are prescribed a CPAP device. Combined with a 50% or 70% PTSD rating using VA combined math, this secondary condition can significantly increase your overall compensation.

The Proposed Rule Change Threat

There is a pending VA rulemaking (RIN 2900-AQ72, published as a Supplemental Notice of Proposed Rulemaking at 89 FR 74162 on September 12, 2024) that would overhaul DC 6847 sleep apnea ratings. If finalized, the new criteria would look dramatically different:

Here is what matters for your claim right now:

Current Status of the Proposed Rule (March 2026)

• The Fall 2024 Unified Regulatory Agenda projected a "Final Rule Stage" completion by August 2025 — that deadline was missed
• Multiple sources (December 2025 through January 2026) project "mid-to-late 2026" implementation, but describe these dates as "speculative and subject to delay or revision"
• Military.net (January 2026) explicitly noted that "delays, modifications, or even cancellation remain possible" under current administration review
• The separate 38 CFR § 4.10 interim final rule (published February 17, 2026) was formally rescinded just 10 days later on February 27, 2026, after massive VSO and congressional pushback (over 20,000 public comments). This demonstrates that regulatory rollbacks are not guaranteed.

Why Sleep Apnea Secondary Claims Get Denied

Understanding why these claims fail is just as important as knowing how they succeed. Based on our review of BVA decisions, here are the most common denial patterns:

1. Negative C&P Exam That Ignores the Obesity Pathway

This is the most common failure mode. BVA decision A25005239 (January 2025) explicitly rejected a VA examiner who "wholly failed to discuss" the obesity intermediate step pathway. The examiner provided a negative opinion on direct causation but never addressed whether PTSD medications caused weight gain that caused OSA.

This happens because the VA's own adjudication manual (M21-1) is structured in a way that creates systematic first-read rater errors on intermediate step claims. The obesity pathway is located in a different section (M21-1 Part V, Subpart ii, Chapter 3, Section C) from where raters typically look for secondary connection guidance. C&P examiners are not incentivized to research secondary nexus pathways and often address only the most obvious direct-causation theory.

2. No Nexus Letter or a Generic Nexus Letter

Claims submitted without any nexus letter, or with a generic letter that says only "PTSD can cause sleep apnea," are significantly weaker. The nexus letter must be individualized to the veteran and must walk through the specific medical mechanisms, cite the veteran's own BMI data, and reference the legal framework.

3. Nexus Letter Submitted After the C&P Exam

This is the most costly timing mistake. Once a C&P examiner issues a negative opinion, VA raters give that opinion significant weight. Submitting a private nexus letter after the fact — even one that is medically stronger — rarely overturns the examiner's opinion at the initial claim level. And after Bufkin v. Collins (SCOTUS, March 2025), if your claim reaches the BVA and is denied on benefit-of-the-doubt grounds, the Court of Appeals for Veterans Claims can only reverse that determination for "clear error" — a much higher bar than de novo review.

4. Outdated "Obesity Is a Lifestyle Choice" Reasoning

Some VA raters and C&P examiners still apply pre-Adams, pre-Garner reasoning that treats obesity as a "lifestyle factor" rather than a recognized intermediate step. This is legally incorrect. The BVA has consistently overturned such denials. But the best strategy is to prevent this error by proactively citing Garner v. Tran and the M21-1 intermediate step provisions in your initial claim submission.

5. Missing Weight Gain Documentation

If your medical records do not show a clear weight gain trajectory that correlates with PTSD treatment, the claim becomes much harder to prove. Veterans who maintained a stable weight both before and after PTSD treatment have a weaker (though not impossible) case on the obesity pathway — they should emphasize the direct neurobiological pathway instead.

How to Build the Strongest Claim

Based on the legal framework, BVA grant patterns, and medical evidence, here is the optimal evidence package for a sleep apnea secondary to PTSD claim.

Step 1: File an Intent to File (VA Form 21-0966)

This locks in your effective date while you assemble your evidence. You have one year from the Intent to File date to submit your full claim. Do this first.

Step 2: Get a Sleep Study

You need a polysomnography or home sleep test confirming an OSA diagnosis with a specific AHI (Apnea-Hypopnea Index) score. If your doctor prescribes a CPAP, that finding alone places you at the 50% rating threshold.

Step 3: Obtain an Individualized Nexus Letter

This is the highest-leverage action in the entire claim process. The nexus letter should:

• Address all four PTSD-to-OSA mechanisms (medication, dopamine/reward, sleep disturbance, direct neurobiological)
• Name specific PTSD medications with start dates and cite VA/DoD 2023 CPG metabolic effects
• Include the veteran's chronological BMI timeline (pre-PTSD weight vs. post-medication weight)
• Walk through the three-part intermediate step test explicitly
• Cite Garner v. Tran factor #3 by name and case citation
• Include quantitative weight-OSA data (10% weight gain = 32% AHI increase)
• State the opinion using "at least as likely as not" language
• If applicable, opine that PTSD prevents habitual CPAP use

Step 4: Complete a Sleep Apnea DBQ

Have your private provider complete the Sleep Apnea Disability Benefits Questionnaire. This ensures the medical findings are documented in the format VA raters expect.

Step 5: Compile Supporting Documentation

• Buddy statements from a spouse, roommate, or anyone who has witnessed your apnea episodes (snoring, gasping, breathing pauses)
• PTSD medication records showing prescription history and start dates
• Weight history extracted from VA medical records showing the progression
• Prior VA obesity-pathway grants: If you have already received service connection for ANY condition via the obesity intermediate step (diabetes, hypertension, cardiovascular disease), that prior determination is near-conclusive evidence of Step 1 for your OSA claim

Step 6: File VA Form 21-526EZ with Explicit Legal Citations

In your claim submission, explicitly cite:

• M21-1 Part V, Subpart ii, Chapter 3, Section C (b-d) — the VA's own adjudication manual recognizing the obesity intermediate step
• Garner v. Tran, 33 Vet. App. 241 (2021) — the six-factor test
• Walsh v. Wilkie (2020) — establishing the intermediate step framework
• Adams v. Collins, No. 23-5064 (CAVC July 2025) — rejecting the categorical prohibition (supplementary authority)

Proactively citing these authorities forces the rater to address the intermediate step theory. Failure to do so creates a specific, appealable legal error.

For Previously Denied Veterans: Three-Track Strategy

If you were previously denied for sleep apnea secondary to PTSD, you have multiple options:

1. Supplemental Claim (VA Form 21-0995): Cite Walsh v. Wilkie and Garner v. Tran as primary new and relevant authority. If your prior denial was based on the categorical prohibition of obesity as a disability, also cite Adams v. Collins as supplementary authority.
2. Hamill "Still Pending" Theory: Under Hamill v. Collins (Fed. Cir., February 4, 2026), which eliminated the implicit denial doctrine, if your prior VA rating decision never explicitly addressed the obesity intermediate step theory, that theory is still legally pending and unadjudicated. This is a novel legal theory — strong in principle but not yet tested in the OSA context specifically.
3. Higher-Level Review: If your denial was based on a rater error (ignoring the obesity pathway, misapplying legal standards), a Higher-Level Review can correct the error without new evidence.